Pamukcu Rifat
SEC CIK 1929298 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| APRE | Aprea Therapeutics, Inc. | Dir | 8,581 | — | — | 7 | 2022-07-28 | 2026-06-16 |
Most active insiders at APRE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duey Marc | Dir | $25.1K | — |
| 2 | Gilad Oren | Pres, CEO, Dir | $25.0K | — |
| 3 | Hamill John P. | CFO, SrVP, Prin Fin, Acct Ofcr | $10.9K | — |
| 4 | Pamukcu Rifat | Dir | — | — |
| 5 | Gruia Gabriela | Dir | — | — |
| 6 | Seizinger Bernd R. | Dir | — | — |
| 7 | Grissinger Michael | Dir | — | — |
| 8 | Peters Richard | Dir | — | — |
| 9 | BIZZARI JEAN-PIERRE | Dir | — | — |
| 10 | HENNEMAN JOHN B III | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-17 19:03 | 2026-06-16 | APRE | Aprea Therapeutics, Inc. | Pamukcu Rifat | Dir | A - Grant | $0.00 | +3,135 | 8,581 | +58% | $0 |
| D | 2025-06-09 | 2025-06-05 | APRE | Aprea Therapeutics, Inc. | Pamukcu Rifat | Dir | A - Grant | $0.00 | +1,045 | 5,446 | +24% | $0 |
| D | 2024-06-21 | 2024-06-20 | APRE | Aprea Therapeutics, Inc. | Pamukcu Rifat | Dir | A - Grant | $0.00 | +1,045 | 4,401 | +31% | $0 |
| D | 2023-08-24 | 2022-08-23 | APRE | Aprea Therapeutics, Inc. | Pamukcu Rifat | Dir | C - Cnv Deriv | $0.00 | +49.3K | 57.1K | +627% | $0 |
| DI | 2023-08-24 | 2022-08-23 | APRE | Aprea Therapeutics, Inc. | Pamukcu Rifat | Dir | C - Cnv Deriv | $0.00 | +271.9K | 14.1K | New | $0 |
| D | 2023-08-24 | 2023-08-23 | APRE | Aprea Therapeutics, Inc. | Pamukcu Rifat | Dir | A - Grant | $0.00 | +500 | 3,356 | +18% | $0 |
| D | 2022-08-01 | 2022-07-28 | APRE | Aprea Therapeutics, Inc. | Pamukcu Rifat | Dir | A - Grant | $0.00 | +5,995 | 7,862 | +321% | $0 |
Purchase Sale Sale after option exercise All abbreviations